Reuters logo
BRIEF-Novavax reschedules 4th annual investor, analyst meeting
October 7, 2016 / 12:36 PM / a year ago

BRIEF-Novavax reschedules 4th annual investor, analyst meeting

Oct 7 (Reuters) - Novavax Inc :

* Continue to analyze data from resolve clinical trial, map out clinical path forward for older adult RSV F vaccine

* Novavax reschedules 4th annual investor and analyst meeting Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below